13F Pro Quality Score

57.6/100

Rank #1,082 of 2,962 stocksTOP 50%

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

36.2/100

Profitability

52.7/100

Balance Sheet

52.6/100

Earnings Quality

77.0/100

Free Cash Flow

71.6/100

Institutional Flow

20.8/100

Revenue Scale

69.1/100

Dilution Risk

63.4/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

RVTY Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for REVVITY, INC. (RVTY), a Technology sector company. 13F Pro's AI-powered ranking engine scores RVTY at 57.6/100 on a 32-signal composite quality model, placing it at rank #1,082 of 2,962 stocks — the top half of the AI-ranked universe. RVTY scores in the top quartile across earnings quality (77.0). Areas of concern include institutional flow (20.8) and revenue growth (36.2), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), REVVITY, INC. reports quarterly revenue of $729.7M, net income of $51.8M, an operating margin of 12.2%. Top institutional holders of RVTY by reported 13-F value include T. Rowe Price Investment Management, Jupiter Topco, EdgePoint Investment Group, based on the most recent SEC filings. RVTY trades on the NYSE exchange and files with the SEC under CIK 31791. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RVTY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for REVVITY, INC. directly from SEC EDGAR. REVVITY, INC.'s 13F Pro composite quality score has ranged between 37 and 60 since 2023, currently 57.6 — a stable long-term trajectory across 59 quarterly and live scoring snapshots.

Fun facts about REVVITY, INC.

Quirks, history, and lore behind RVTY — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. life sciences technology company · mid-cap · listed on Nasdaq · headquartered in Massachusetts.
  • 2
    The Numbers
    Annual revenue in the range of roughly $2–3 billion, with operations spanning more than 30 countries and thousands of employees worldwide.
  • 3
    The History
    The company you know today emerged from the 2023 rebranding of a storied scientific instruments giant, shedding a legacy name that had been around since the 1930s.
  • 4
    The Secret
    It spun off its industrial and environmental testing business to focus purely on human and environmental health — diagnostics, genomics, and drug discovery tools.
  • 5
    The Lore
    Its predecessor, PerkinElmer, was itself the product of a merger between two venerable scientific firms — one of which traces its roots to Nobel laureate Emilio Segrè's era of atomic science.
  • 6
    The Giveaway
    Formerly traded as PerkinElmer, it rebranded with a snappy new name and ticker to signal its pure-play focus on life science diagnostics and tools — the old name is gone, but the pipettes remain.
▶ Think you know your stocks? Play the Daily Ticker

What's Driving RVTY's Business? Latest 10-Q Breakdown

19/19 datapoints verified

AI-extracted from REVVITY, INC.'s 10-Q filed 2026-08-11 — Q2 FY2026 (quarter ended July 5, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Revvity delivered $729.7M in Q2 revenue (+1% YoY), with Diagnostics segment surging 5% driven by Reproductive Health, though Life Sciences declined 2% on Software weakness.

Biggest Revenue Drivers

Diagnostics$371.0M+5% YoY

Reproductive Health revenue increased $20.7M, partially offset by $4.1M decline in Immunodiagnostics.

Life Sciences$358.7M-2% YoY

Software revenue decreased $10.2M, partially offset by $3.0M increase in Life Sciences Solutions revenue.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Revenue

Q2 2026

$729.7M

Net Income

Q2 2026

$51.8M

Free Cash Flow

Q2 2026

$180.9M

Operating Margin

Q2 2026

12.2%

ROIC

Q2 2026

3.4%

D/E Ratio

Q2 2026

0.45

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+3.7% YoY
$2.86BFY 2025
FY22 $3.31BFY23 $2.75BFY24 $2.76BFY25 $2.86B

Net Income

-10.8% YoY
$241.2MFY 2025
FY22 $569.2MFY23 $693.1MFY24 $270.4MFY25 $241.2M

Operating Income

+2.9% YoY
$356.6MFY 2025
FY22 $742.7MFY23 $300.6MFY24 $346.7MFY25 $356.6M

EPS (Diluted)

-5.9% YoY
$2.07FY 2025
FY22 $4.50FY23 $5.55FY24 $2.20FY25 $2.07

Total Assets

-1.8% YoY
$12.17BFY 2025
FY22 $14.13BFY23 $13.56BFY24 $12.39BFY25 $12.17B

Total Debt

+2.1% YoY
$3.24BFY 2025
FY22 $4.43BFY23 $3.93BFY24 $3.17BFY25 $3.24B

Op. Cash Flow

-7.2% YoY
$582.9MFY 2025
FY22 $679.8MFY23 $91.3MFY24 $628.3MFY25 $582.9M

Free Cash Flow

-6.0% YoY
$509.4MFY 2025
FY22 $594.2MFY23 $9.9MFY24 $541.7MFY25 $509.4M

Get alerted when RVTY's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for REVVITY, INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of RVTY

Companies Similar to RVTY

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

FTV

Fortive Corp

57
AI score
Similar quality profile · 19 shared holders
ST

Sensata Technologies Holding plc

51
AI score
Similar quality profile · 17 shared holders
TRMB

TRIMBLE INC.

51
AI score
Similar quality profile · 17 shared holders
SWKS

SKYWORKS SOLUTIONS, INC.

52
AI score
Similar quality profile · 19 shared holders
CTSH

COGNIZANT TECHNOLOGY SOLUTIONS CORP

64
AI score
Similar quality profile · 15 shared holders
ON

ON SEMICONDUCTOR CORP

55
AI score
Similar quality profile · 10 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put RVTY on your watchlist

Track score changes the day REVVITY, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is RVTY a good stock to buy?

13F Pro's AI-powered analysis of REVVITY, INC. (RVTY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for RVTY are available on the RVTY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. RVTY is classified as a large company.

Which hedge funds own RVTY?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling RVTY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of REVVITY, INC.'s investment landscape.